World Library  
Flag as Inappropriate
Email this Article

Lipodystrophy

Article Id: WHEBN0000249962
Reproduction Date:

Title: Lipodystrophy  
Author: World Heritage Encyclopedia
Language: English
Subject: Laminopathy, Familial partial lipodystrophy, HIV-associated lipodystrophy, Lipomatosis, Abdominal obesity
Collection: Conditions of the Subcutaneous Fat
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Lipodystrophy

Lipodystrophy
Classification and external resources
ICD-10 E88.1
ICD-9-CM 272.6
DiseasesDB 30066
eMedicine med/1307 med/3523
MeSH D008060

Lipodystrophy is a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. ("Lipo" is Greek for "fat", and "dystrophy" is Greek for "abnormal or degenerative condition".) A more specific term, lipoatrophy, is used when describing the loss of fat from one area (usually the face). This condition is also characterized by a lack of circulating leptin which may lead to osteosclerosis.

Contents

  • Types 1
  • Insulin injections 2
  • Antiretroviral drugs 3
  • Hereditary forms 4
  • Patient Foundation 5
  • See also 6
  • References 7
  • External links 8

Types

Lipodystrophy can be divided into the following types:[1]:495–7

  • Congenital lipodystrophies
  • Acquired lipodystrophy

Insulin injections

A lipodystrophy can be a lump or small dent in the skin that forms when a person performs injections repeatedly in the same spot. These types of lipodystrophies are harmless and can be avoided by changing (rotating) the locations of injections. For those with diabetes, using purified insulins may also help.

One of the side-effects of lipodystrophy is the rejection of the injected medication, the slowing down of the absorption of the medication, or trauma that can cause bleeding that, in turn, will reject the medication. In any of these scenarios, the dosage of the medication, such as insulin for diabetics, becomes impossible to gauge correctly and the treatment of the disease for which the medication is administered is impaired, thereby allowing the medical condition to worsen.

In some cases, rotation of the injection sites may not be enough to prevent lipodystrophy.

Antiretroviral drugs

Lipodystrophies can be a possible side effect of antiretroviral drugs. Other lipodystrophies manifest as lipid redistribution, with excess, or lack of, fat in various regions of the body. These include, but are not limited to, having sunken cheeks and/or "humps" on the back or back of the neck (also referred to as buffalo hump)[2] which also exhibits due to excess cortisol. Lipoatrophy is most commonly seen in patients treated with thymidine analogue nucleoside reverse transcriptase inhibitors [3] like zidovudine (AZT) and stavudine (d4T).[4]

Hereditary forms

Lipodystrophy can be caused by metabolic abnormalities due to genetic issues. These are often characterized by insulin resistance and are associated with metabolic syndrome.

Patient Foundation

Lipodystrophy United is a Non-Profit Organization created by lipodystrophy patients to provide community support and awareness.

See also

References

  1. ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier.  
  2. ^ Physical and Biochemical Changes in HIV Disease Eric S. Daar, M.D. MedicineNet, Accessed 22 September 2007
  3. ^ Carr, A; Workman, C; Smith, DE; Hoy, J; Hudson, J; Doong, N; Martin, A; Amin, J; Freund, J; Law, M; Cooper, DA; Mitochondrial Toxicity (MITOX) Study, Group (Jul 10, 2002). "Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.". JAMA: the Journal of the American Medical Association 288 (2): 207–15.  
  4. ^ John, M; McKinnon, EJ; James, IR; Nolan, DA; Herrmann, SE; Moore, CB; White, AJ; Mallal, SA (May 1, 2003). "Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients.". Journal of acquired immune deficiency syndromes (1999) 33 (1): 29–33.  

External links

  • Lipodystrophy Patient Registry - register to learn from the community!
  • DermAtlas 1847886158
  • TheBody: The Lipoatrophy Resource Center
  • Lipodystrophy United Patient Advocacy
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.